Products & safety
Fumonisins: corn contamination, B-type forms, intake guidance and human-evidence limits
On this page
Fumonisins are Fusarium fungal toxins commonly associated with maize or corn. The B-type family has related compounds. Contamination and the amount consumed are separate parts of exposure assessment.[1]
Parent, modified and hidden forms are distinct
FB1 is the most common B-type fumonisin, followed by related members such as FB2 and FB3. Modified forms have undergone chemical changes; hidden forms can be physically entrapped and poorly recovered by routine extraction. Those categories describe chemistry and measurement, not a guarantee of harmlessness. EFSA explains that a food result depends partly on what the method extracts and measures. A report labeled total fumonisins should specify its included compounds and whether it addresses relevant modified or hidden material.[6]
Corn fractions can have different contamination
FDA distinguishes degermed products, whole or partially degermed products, bran, masa corn and popcorn. Categories reflect products and achievable control levels. Weather and manufacturing influence contamination. A category cannot supply a concentration for a particular purchase.[1]
Keep commodity limits separate from a daily dose
FDA recommends 2 parts per million total FB1, FB2 and FB3 for degermed dry-milled corn products and 4 ppm for several whole or partially degermed products and corn intended for masa. These are recommended guidance levels, presented as achievable with good agricultural and manufacturing practices. Milligrams per kilogram food, micrograms per kilogram body weight per day and percentages of animal feed are different denominators. The amount eaten and body weight connect food concentration to an intake estimate.[1]
Evidence & uncertainty
Animal and mechanistic evidence supports prevention, while human-risk estimates remain uncertain. Agency groups differ. Corn concentration and body-weight-based daily intake are distinct quantities.[3]
Selected-source overview · Independent review pendingPublished questions
Does total fumonisins always include the same chemicals?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA's listed total uses FB1, FB2 and FB3; EFSA's 2018 group includes FB4 too. Reports should identify which compounds were measured.[1][2]
Evidence behind this answer
- Fumonisin Levels in Human Foods and Animal Feeds
agency guidance or assessment · 2001
Original official page and selected relevant passages inspected · Background, FB1+2+3 and commodity-specific recommended levels - Group health-based guidance value for fumonisins and modified forms
agency scientific opinion · 2018
Original official page and selected relevant passages inspected · Abstract and summary: FB1–4 TDI, mouse endpoint and excluded modified forms
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is there one US guidance value for every corn product?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA distinguishes product fractions and intended uses. Degermed dry-milled products and several whole or partially degermed products have different recommended levels.[1]
Evidence behind this answer
- Fumonisin Levels in Human Foods and Animal Feeds
agency guidance or assessment · 2001
Original official page and selected relevant passages inspected · Background, FB1+2+3 and commodity-specific recommended levels
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does exclusion from the group prove modified forms safe?
Selected-source overview · Independent review pending. Read the evidence context.
No. EFSA excluded modified forms because toxicology and occurrence information were insufficient for inclusion. Absence of adequate data is not evidence of harmlessness.[2]
Evidence behind this answer
- Group health-based guidance value for fumonisins and modified forms
agency scientific opinion · 2018
Original official page and selected relevant passages inspected · Abstract and summary: FB1–4 TDI, mouse endpoint and excluded modified forms
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does the tortilla study prove every serving is dangerous?
Selected-source overview · Independent review pending. Read the evidence context.
No. It was an observational study with recalled exposure and a postpartum biomarker. It supports further investigation, not an individual per-serving risk prediction.[5]
Evidence behind this answer
- Fumonisin exposure and neural tube defects along the Texas–Mexico border
original case control study · 2006
Indexed original full-text sections inspected; direct PubMed retrieval was empty · Indexed original study methods, biomarker timing and highest-category finding
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can a worldwide average represent a high-exposure maize community?
Selected-source overview · Independent review pending. Read the evidence context.
Not necessarily. JECFA identified regional data gaps and non-detect assumptions that influence estimates; local staple consumption and contamination can differ.[3]
Evidence behind this answer
- 83rd JECFA meeting: summary and conclusions
agency technical assessment · 2016
Selected original report sections inspected · Fumonisins pages 3–4: 2 μg/kg/day group, bounds and geographic gaps
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can a horse-feed number be applied to people?
Selected-source overview · Independent review pending. Read the evidence context.
No. Species susceptibility, feed share, concentration units and the assessment purpose differ. Animal-feed advice requires its own context.[6]
Evidence behind this answer
- Toxicity of fumonisins for pigs, poultry and horses
agency scientific opinion · 2022
Original official page and selected relevant passages inspected · Abstract and chemistry: species reference points, B-types and hidden forms
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
A disrupted pathway explains concern without proving every human outcome
Mechanistic work describes inhibition of ceramide synthase and changes in sphingolipid metabolism. These changes can affect membrane proteins involved in folate transport. Embryo culture and mouse experiments support a developmental-harm hypothesis. They establish biological plausibility, not the probability of a birth defect after eating a particular tortilla. Species, dose and exposure timing matter, and a nutritional rescue observed experimentally is not a prescribed antidote for people.[4]
EFSA and JECFA use different groups and reference values
EFSA's 2018 assessment set a group tolerable daily intake of 1 microgram per kilogram body weight per day for FB1–FB4, based on a chronic mouse study and related-compound evidence. It excluded modified forms because the evidence was insufficient for inclusion, not because they were proven harmless. JECFA's 2016 evaluation retained 2 micrograms per kilogram per day for FB1–FB3. Compound coverage and assessment derivation must remain visible when comparing the numbers.[2][3]
An observational pregnancy study has timing limitations
A Texas–Mexico border case-control study examined tortilla-related exposure and sphinganine-to-sphingosine ratios in mothers of pregnancies affected or unaffected by neural tube defects. It reported associations except in the highest biomarker category. The biomarker was measured five to six weeks postpartum, after the relevant early developmental window, and diet was recalled. These limitations complicate causal interpretation. The study should neither be ignored nor rewritten as proof that all corn consumption causes birth defects.[5]
Non-detects and regional coverage change estimated exposure
JECFA emphasized that many occurrence results were non-detects and that different assumptions about them changed lower- and upper-bound exposure estimates. It also highlighted missing data from regions where maize is a staple and contamination can be high. A low average across the available database does not necessarily represent every high-exposure community. New, representative local measurements and suitable detection limits can matter more than a global headline or an untested food label.[3]
Animal-feed advice cannot be copied into human diets
EFSA's 2022 reassessment of pigs, poultry and horses revised some animal reference points and retained others, while acknowledging uncertainty. This illustrates differences in susceptibility and evidence across species. A feed concentration, the share of that ingredient in a ration and a human daily intake are not interchangeable. Food-system prevention and tested commodity controls remain useful even when the exact human contribution to particular diseases is unresolved; this page does not provide individual pregnancy-risk prediction or treatment.[6]
References
- Fumonisin Levels in Human Foods and Animal Feeds
Agency guidance or assessment
US FDA · Content/publication date: 2001
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Background, FB1+2+3 and commodity-specific recommended levelsSelected-source access only; check date is distinct from publication date. No independent expert review.
- Group health-based guidance value for fumonisins and modified forms
Agency scientific opinion
EFSA · Content/publication date: 2018
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Abstract and summary: FB1–4 TDI, mouse endpoint and excluded modified formsSelected-source access only; check date is distinct from publication date. No independent expert review.
- 83rd JECFA meeting: summary and conclusions
Agency technical assessment
FAO/WHO JECFA · Content/publication date: 2016
Accessed: 2026-10-13 UTC · Selected original report sections inspected
Cited sections: Fumonisins pages 3–4: 2 μg/kg/day group, bounds and geographic gapsSelected-source access only; check date is distinct from publication date. No independent expert review.
- Fumonisins disrupt sphingolipid metabolism, folate transport and neural tube development
Original mechanistic research article
Marasas et al. · Content/publication date: 2004
Accessed: 2026-10-13 UTC · Original scientific article abstract inspected; experimental model limits retained
Cited sections: Abstract: ceramide synthase, experimental models and developmental hypothesisSelected-source access only; check date is distinct from publication date. No independent expert review.
- Fumonisin exposure and neural tube defects along the Texas–Mexico border
Original case control study
Missmer et al. · Content/publication date: 2006
Accessed: 2026-10-13 UTC · Indexed original full-text sections inspected; direct PubMed retrieval was empty
Cited sections: Indexed original study methods, biomarker timing and highest-category findingSelected-source access only; check date is distinct from publication date. No independent expert review.
- Toxicity of fumonisins for pigs, poultry and horses
Agency scientific opinion
EFSA · Content/publication date: 2022
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Abstract and chemistry: species reference points, B-types and hidden formsSelected-source access only; check date is distinct from publication date. No independent expert review.
Scope & review
- Population
- General readers; food exposure, occupational settings and vulnerable populations are distinguished where relevant
- Exposure or intervention
- Fumonisins
- Comparison
- Chemical forms, routes, dose and duration; health guidance versus product limits
- Outcomes
- Identity, everyday sources, evidence, practical interpretation and uncertainty
- Timeframe
- Selected sources checked 2026-10-13; historical evidence is dated separately
- Jurisdiction
- US and explicitly identified European or international sources; local rules differ
Bounded selected-source educational explanation. Official assessments, original studies and editorial inference are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added definition-first explanation, categories, practical questions and source-linked uncertainty.
What this article still leaves open
- No product-specific safety certificate or individualized exposure diagnosis is provided.
- Jurisdiction-specific implementation, sampling methods and newly published evidence require separate assessment.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.